Bio-Manguinhos Report issue

Academic/Hospital Phase 1
Founded: Rio de Janeiro Brazil

Organization Overview

First Clinical Trial
2008
NCT01874457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Immunobiological Technology Institute (Bio-Manguinhos)